Development and Application of a “Chelate to Release” labeling platform for synthesis of high molar activity radiopharmaceuticals

01.04.2022 - 31.03.2026
Research funding project

People

Project leader

Institute

Grant funds

  • FFG - Österr. Forschungsförderungs- gesellschaft mbH (National) Programm BRIDGE Programme BRIDGE Austrian Research Promotion Agency (FFG)

Research focus

  • Biological and Bioactive Materials: 50%
  • Special and Engineering Materials: 50%

External partner

  • DSD Pharma GmbH
  • Medizinische Universität Wien

Publications